[Recent data on endometriosis].

article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-09

This paper reviews endometriosis, a disorder affecting young women characterized by ectopic endometrial tissue and leading to sterility, with treatments like LHRH analogs showing an 87 percent improvement rate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a common disorder in young women of childbearing age and it leads to sterility in 25 to 30 percent of cases. This disorder, which is characterized by the heterotopical presence of endometrial tissue, has a complex physiopathology, which involves the tubal reflux of blood during the menses as well as immune theories involving the formation of autoantibodies to the endometrial cells. Treatment is based on producing a lower level of estrogen production, by administering LHRH analogs or danazol. LHRH analogs, such as nafareline, have no secondary metabolic effects and achieve a successful therapeutic response, with an 87 percent improvement rate as detected by celioscopy.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Gonadotropin-Releasing Hormone Uterine Neoplasms Danazol Danazol Danazol Endometriosis Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Laparoscopy Nafarelin Severity of Illness Index Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-11T06:11:44.160905+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:54.876058+00:00
License: CC0 · commercial use OK